Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,103 recruiting studies in this area right now.
By phase
- Not applicable4,204
- Phase 2591
- Phase 1413
- Phase 3328
- Phase 4255
- Phase 1/Phase 2245
- Phase 2/Phase 367
Top conditions
- Ovarian Cancer338
- Cervical Cancer226
- Endometrial Cancer210
- Bladder Cancer187
- Acute Kidney Injury135
- Endometriosis132
- Pregnancy129
- Chronic Kidney Diseases123
- Breast Cancer111
- Chronic Kidney Disease108
- Infertility91
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension59
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS45
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong34
Where studies are running
- California351
- Alabama154
- Texas118
- Massachusetts117
- New York117
- Arizona106
- Florida103
- Maryland87
- Colorado84
- Illinois79
Recruiting studies6,103 total
- NCT04704115Recruiting
Treatment for large endometrioma cysts
This trial studies a treatment approach for women with a large endometrioma (an endometriosis-related ovarian cyst). It may help reduce symptoms and treat the cyst, but you can join only if certain imaging and safety requirements are met.
Lisle-sur-TarnAges 18–40 - NCT05201469RecruitingPhase 2
VIB4920 for lupus kidney inflammation not responding well enough
This Phase 2 study tests VIB4920 to treat active lupus nephritis, a type of kidney disease caused by lupus. It may help reduce kidney inflammation and improve kidney outcomes in people with active disease despite standard care.
La Jolla, CaliforniaAges 18 years+ - NCT05208762RecruitingPhase 1
PD-L1 antibody drug study for advanced lung and head/neck cancers
This Phase 1 trial tests a new experimental drug (PF-08046054/SGN-PDL1V) in people with advanced solid tumors that have not responded to standard treatment or can’t use it. It is designed to see how the drug works and how safe it is, with a focus on tumors that have PD-L1 seen on prior lab testing.
Birmingham, AlabamaAges 18 years+ - NCT05200923Recruiting
Testing a pelvic nerve device study for bladder and bowel leaks
This study checks how well an implanted pelvic nerve system works for people with bladder overactivity, non-obstructive urinary retention, or fecal incontinence. You may need to keep your current medications steady and track symptoms closely with diaries before and during evaluation.
Indianapolis, IndianaAges 18 years+ - NCT05248659Enrolling by invitationPhase 2/Phase 3
Sibeprenlimab for IgA kidney disease after prior study
This trial studies sibeprenlimab to see if it can improve IgA nephropathy, a kidney inflammation condition. You may be able to join if you finished a previous related Otsuka study without major safety problems and your doctor thinks you could benefit.
Birmingham, AlabamaAges 18 years+ - NCT05201131Recruiting
Study of Rezūm treatment for enlarged prostate in Canadian patients
This study looks at outcomes from the Rezūm procedure for men with an enlarged prostate (BPH). You may be asked to complete questionnaires and follow the study plan to help researchers understand how well this treatment works and is tolerated.
Toronto, OntarioAges 18 years+ - NCT05213806Recruiting
Pausing feeding during blood transfusions for very premature babies
This trial looks at whether it’s safer to temporarily withhold (pause) breast milk or formula feeds around the time of a blood transfusion in very premature babies. It may help reduce gut-related complications like NEC, a serious intestinal problem.
Halifax, Nova ScotiaAges Up to 7 months - NCT05224726Recruiting
Platelet-rich plasma for healing after C-section
This study tests whether a treatment made from your own platelets (platelet-rich plasma) can help the uterus heal after an elective C-section. You may be considered if you are full-term and having a planned C-section.
Ramat Gan, CenterAges 18–52 - NCT05255653RecruitingPhase 3
Adjuvant treatment for high-risk endometrial cancer based on tumor genetics
This trial tests whether adding an immunotherapy drug called durvalumab to the usual treatment can improve outcomes for people with a specific genetic type of endometrial cancer that is at high risk of returning. It is designed for people who have already had surgery to remove the cancer.
AntwerpAges 18 years+ - NCT05225363RecruitingPhase 1
CAR T therapy for ovarian cancer that no longer responds to platinum
This Phase 1 study tests a one-time treatment made from your immune cells (CAR T) to attack a protein found on some ovarian cancer cells. It is for people whose ovarian cancer has come back or worsened after platinum chemotherapy, aiming to see safety and early signs of benefit.
Duarte, CaliforniaAges 18 years+ - NCT05231122RecruitingPhase 2
Pembrolizumab and bevacizumab for recurrent ovarian cancer
This trial studies whether adding pembrolizumab to bevacizumab (and sometimes an anti-CD40 drug) can help control recurrent ovarian, fallopian tube, or primary peritoneal cancer. It also looks at whether the treatment can shrink tumors and keep them from growing for longer.
Buffalo, New YorkAges 18 years+ - NCT05206682Recruiting
Treating C-section scar defect with hormones versus surgery alone
This trial compares two treatments for a pregnancy-related problem in the uterus: vaginal repair alone versus vaginal repair plus leuprorelin (a hormone medicine). It aims to improve symptoms like long or heavy bleeding when a C-section scar defect is also linked with adenomyosis.
Shanghai, Shanghai MunicipalityAges 18–50 - NCT05229666Recruiting
Study stress patterns in early pregnancy and preterm birth risk
This study looks at how stress shows up in the body during early pregnancy and whether it’s linked to preterm birth (birth before 37 weeks). You may be asked about your stress and health to help researchers understand who is at higher risk.
New York, New YorkAges 18 years+ - NCT05231993Enrolling by invitation
Treats HPV-positive atypical cervical cells found on screening
This study is for women whose cervical screening shows atypical glandular cells and who test positive for HPV types 16 or 18. It aims to decide the best way to triage and manage these findings so people get the right follow-up and treatment.
StockholmAges 23–64 - NCT05227937Recruiting
Single-dose antibiotic for uncomplicated bladder infection in the ER
This study tests whether giving one dose of amikacin in the emergency department is practical and safe for treating uncomplicated bladder infections. It also looks at how patients do after treatment over the next 3, 7, and 30 days.
Brooklyn, New YorkAges 14–110 - NCT05242315RecruitingPhase 4
Long-acting tacrolimus after liver transplant
This trial studies whether taking an extended-release form of tacrolimus (a medicine to prevent transplant rejection) after a liver transplant works well for people who are followed at the University of Alberta. It may help simplify dosing and monitor safety and effectiveness after transplant.
Edmonton, AlbertaAges 18 years+ - NCT05246579Recruiting
Tracking ways to prevent preterm birth
This study looks at different care pathways to help lower the risk of preterm birth (birth too early). It will follow pregnant people with a singleton pregnancy to see which approaches may work best for preventing early delivery.
Lexington, KentuckyAges 18–45 - NCT05205317Recruiting
VR alone or VR plus metformin for C-section scar healing
This study compares two treatments to help improve a C-section scar defect (an issue seen on the uterus scar). Some participants may receive virtual reality (VR) therapy plus metformin, while others receive VR alone, and the researchers will look at symptoms and scar healing.
Shanghai, Shanghai MunicipalityAges 18–40 - NCT05223192Recruiting
Testing music to improve breathing and brain oxygen in preemies
This study looks at whether planned music sessions can help preterm babies breathe more steadily and improve oxygen reaching the brain. It may help staff learn how to use music therapy safely for newborns in the NICU.
New York, New YorkAges 6 months–9 months - NCT05251324Recruiting
Study effects of hot flushes on heart and blood pressure
This study looks at how hot flushes (also called hot flashes) may affect heart function and blood pressure in postmenopausal people. You may be able to take part if you are not currently using hormone therapy or can stop it for the study.
Minneapolis, MinnesotaAges 40–70 - NCT05197621Recruiting
Study how COVID-19 affects pregnancy and newborn outcomes
This study looks at how COVID-19 and COVID vaccination during pregnancy may affect mothers and newborns. Your team will collect health information around delivery to understand what outcomes are most common.
Baltimore, MarylandAges 14–55 - NCT05249634RecruitingPhase 2
Testosterone treatment study for men with chronic kidney disease
This Phase 2 study tests whether testosterone therapy can help men with chronic kidney disease who have low testosterone and related symptoms. It looks to see if treatment is safe and beneficial, while carefully checking heart, blood, prostate, and clotting risks.
St Louis, MissouriAges 18–85 - NCT05237141RecruitingPhase 4
Etonogestrel implant for emergency contraception
This trial studies whether placing an etonogestrel hormonal implant can work as emergency contraception and prevent pregnancy. You may be a good candidate if you have regular periods and are not currently pregnant or trying to get pregnant.
Aurora, ColoradoAges 18–40 - NCT05254041Recruiting
Testing suction to help remove an IUD with a menstrual cup
This study looks at whether gentle suction can help safely remove an IUD when using a menstrual cup at the same time. It may help if your IUD needs removal, and the researchers are testing a specific removal method.
Denver, ColoradoAges 18–45
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,103 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,012 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.